Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 13, 2018

SELL
$102.37 - $117.25 $1.05 Million - $1.2 Million
-10,239 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$98.19 - $115.2 $453,343 - $531,878
4,617 Added 82.12%
10,239 $1.09 Million
Q4 2017

Feb 13, 2018

BUY
$100.43 - $118.09 $256,699 - $301,838
2,556 Added 83.37%
5,622 $615,000
Q3 2017

Nov 13, 2017

BUY
$96.72 - $109.26 $67,510 - $76,263
698 Added 29.48%
3,066 $332,000
Q2 2017

Aug 16, 2017

SELL
N/A
-239,523 Reduced 99.02%
2,368 $240,000
Q2 2017

Aug 15, 2017

BUY
N/A
241,891
241,891 $240,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Koch Industries Inc Portfolio

Follow Koch Industries Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koch Industries Inc, based on Form 13F filings with the SEC.

News

Stay updated on Koch Industries Inc with notifications on news.